You are using an older browser version. Please use a supported version for the best MSN experience.

'A special day': End of Pfizer trial paves way for a COVID shot this year

Final results from Pfizer Inc's COVID-19 vaccine trial showed its shot had a 95% success rate and two months of safety data, paving the way for the drugmaker to apply for an emergency U.S. authorization within days, it said on Wednesday. Soraya Ali reports.

UP NEXT

UP NEXT

image beaconimage beaconimage beacon